New imaging technique could simplify brain surgery for Parkinson's
NCT ID NCT05910008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using a special scanner (O-ARM) in the operating room is as good as standard imaging done before surgery for placing brain electrodes in Parkinson's patients. 24 people took part, and researchers measured how accurately the electrodes were placed. The goal was to see if the O-ARM method could make the procedure more efficient without losing accuracy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that using O-ARM imaging during surgery is just as accurate as standard imaging, potentially simplifying the procedure.
- What could go wrong
- This is a small, completed study with only 24 participants, so results may not apply to all patients. It compares imaging techniques, not a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Feb 2024
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with a diagnosis of idiopathic Parkinson's disease at the stage of motor fluctuations despite optimal medical treatment * Indication for Deep Brain Stimulation (DBS) of the subthalamic nucleus approved by the local multidisciplinary deep brain stimulation committee after an operability assessment (see Appendix) * Informed and signed patient consent * Affiliation to a social security scheme Exclusion Criteria: * Significant cognitive decline assessed in a dedicated multidisciplinary consultation * Contraindication to Magnetic Resonance Imaging (MRI) * Presence of pathologies contraindicating deep brain stimulation * No contraceptive treatment for women of childbearing age * Pregnant or breastfeeding woman * Anticoagulant or antiaggregant treatment that cannot be stopped * Persons under legal protection (persons deprived of liberty or incapable of giving consent or under guardianship or tutelage...) * Patient with severe psychiatric disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Toulouse
Toulouse, 31000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Spinal cord stimulation put to the test for Parkinson's freezing of gait
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Giving Parkinson's patients a say may boost their Brain's ability to learn movement
- Brain scans probe why some Parkinson's patients freeze Mid-Step